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Disease in Korea?The world experiences two imminent public health
events: The Ebola outbreak and the Global Health
Security Agenda (GHSA). Since the first case of Ebola
outbreak in West Africa was confirmed, the total
number of suspected and confirmed cases has
increased to 13,241, including 8,142 laboratory-
confirmed cases and 4,950 deaths in Guinea, Sierra
Leone, Liberia, Nigeria, Mali, Senegal, Spain, and the
United States as of November 4, 2014 [1]. The Ebola
outbreak in West Africa highlights the urgency for
immediate action to establish global health security
capacity to prevent, detect, and rapidly respond to
biological threats like Ebola. The GHSA was launched
on February 13, 2014, to advance a world safe and
secure from infectious disease threats and to bring
together nations from all over the world to make new,
concrete commitments, and to elevate global health
security as a national leaders-level priority [2].The G7
endorsed the GHSA in June 2014. Finland and
Indonesia hosted commitment development meetings
to spur action in May 2014 and August 2014. Ministers
and senior officials from 44 countries and leading in-
ternational organizations gathered in the White House
to make specific commitments to implement the
GHSA and to work toward a commitment to assist
West Africa with the needed global health security
capacity within 3 years.
In 2011, there were an estimated 8.7 million new
cases of active tuberculosis (TB) worldwide, of which
1.1 million (12.6%) people were reported to be infected
with human immunodeficiency virus (HIV). In 2012,
320,000 deaths (36%) of HIV-infected individuals were
related to TB [3]. Recently, 35,000 new cases of TB
were reported in the Republic of Korea, with
2,000e3,000 deaths (5/100,000 persons) related to TBThis is an Open Access article distributed under the terms of
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Korea constructed a national TB control system in
1962, and since then public health centers have con-
ducted several programs on prevention of TB and
workshops for registration and management of TB pa-
tients; in addition, various camps were also conducted
for early detection and treatment of TB patients [6].
Since the first HIV-infected person was diagnosed in
1985, HIV tests have been conducted in public health
centers. However, with an increase in income, more
coverage of health insurance, and enhancement of pri-
vate medical institutions, more TB or HIV tests have
been performed in clinics and hospitals. As a result,
more TB patients and HIV-infected individuals are
identified in clinics and hospitals [7].
In this special issue of the Osong Public Health and
Research Perspectives, we have collected papers that
reported on the recent issues of TB in Korea. Two in-
stitutions are introduced in this issue: The Korean Na-
tional Tuberculosis Association (KNTA) and the Korean
Institute of Tuberculosis (KIT). The KNTA set up the
KIT in 1970 for fostering research and technical activ-
ities. The KNTA/KIT had successfully conducted a
countrywide TB prevalence survey from 1965 to 1995 at
5-year intervals. The survey results (decline in TB rates)
established Korea as a country with successful imple-
mentation of national control programs for TB. The KIT
developed the Korea Tuberculosis Surveillance System
and the Laboratory Management Information System,
both of which were transferred to the Korea Centers for
Disease Control and Prevention after its establishment.
The KIT functions as a central and supranational
reference TB laboratory for microbiological and epide-
miological research and provides training and education
for health care workers and medical practitioners.
Recently, the KIT has expanded its activities to coun-
tries such as Ethiopia, Laos, and Timor-Leste to support
TB control and prevention. The KIT will continue to
support research activities and provide technical assis-
tance in diagnosing the infection until it is completely
eliminated in Korea [8].. Published by Elsevier Korea LLC. All rights reserved.
S2 EditorialRelapse or reinfection is another issue related to TB
infection in Korea. A previous study on the factors
affecting reinfection of TB proposed a mathematical
model [9]. This issue includes a paper to identify the
status of relapse/reinfection in Korea using nationwide
tuberculosis notification data [10] and trends in the
utilization of laboratory tests for TB and mycobacterial
diseases in the private sector by analyzing the National
Health Insurance database. Kim et al [11] analyzed the
insurance data (number and cost) of laboratory tests in
relation to TB and mycobacterial diseases from 2007 to
2012. The authors searched utilization information and
the number of tests and their cost on the website of the
Health Insurance Review and Assessment Service using
the code for each test [11]. There is also a study on HIV
co-infection of suspected TB cases visiting public health
centers [12].
TB is still a burden to national health in Korea, and
therefore it is necessary to identify the status and char-
acteristics of TB infection with national data and na-
tional institutions for establishing prevention and control
policy.
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